Diagnostic value of heart-type fatty-acid binding protein in serum for non-ST-elevation acute coronary syndromes

YU Hongbo, LIU Yang, LUO Junqing, LIU Xinguo, JIAN Ming, HUANG Meiliang, LUO Dan, LI Xuefeng

Medical Journal of the Chinese People Armed Police Forces ›› 2015, Vol. 26 ›› Issue (2) : 133-135.

PDF(593 KB)
PDF(593 KB)
Medical Journal of the Chinese People Armed Police Forces ›› 2015, Vol. 26 ›› Issue (2) : 133-135.
ORIGINAL ARTICLES

Diagnostic value of heart-type fatty-acid binding protein in serum for non-ST-elevation acute coronary syndromes

  • YU Hongbo1, LIU Yang1, LUO Junqing2, LIU Xinguo3, JIAN Ming4, HUANG Meiliang1, LUO Dan1, LI Xuefeng4
Author information +
History +

Abstract

Objective To study the diagnostic value of serum heart-type fatty-acid binding protein(H-FABP)for non-ST-elevation acute coronary syndromes(NSTE ACS). Methods H-FABP and cTnI were measured and compared in 115 NSTE ACS patients and 69 non-cardiac chest pain patients. Results The H-FABP levels were (459±312) pg/ml, (237±169) pg/ml in NSTE ACS group and non-cardiac chest pain group respectively, and there was a significant difference between the two groups(P<0.05).In NSTE ACS group, the H-FABP level of UAP group was (340±285) pg/ml which was lower than NSTE AMI group (592±289) pg/ml, and there was a significant difference between the two groups(P<0.05). For the diagnosed NSTE AMI, the area under the ROC curve of H-FABP was 0.863, the sensitivity was 97.1%, specificity was 47.6%; while for the cTnI were 0.799, 61.2%, 93.9%.Conclusions H-FABP is a highly sensitivie marker of the early NSTE ACS and H-FABP detection is conducive to diagnosis of NSTE ACS.

Key words

non-ST-elevation acute coronary syndrome / heart-type fatty-acid binding protein

Cite this article

Download Citations
YU Hongbo, LIU Yang, LUO Junqing, LIU Xinguo, JIAN Ming, HUANG Meiliang, LUO Dan, LI Xuefeng. Diagnostic value of heart-type fatty-acid binding protein in serum for non-ST-elevation acute coronary syndromes[J]. Medical Journal of the Chinese People Armed Police Forces. 2015, 26(2): 133-135

References

[1] Reibis R, Voller H, Gitt A et al. Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers [J]. Clin Cardiol, 2014, 37(4): 213-221.
[2] Meier P, Lansky A J, Baumbach A. Almanac 2013: acute coronary syndromes [J]. Acta Cardiol, 2014, 69(1): 100-108.
[3] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J]. 中华心血管病杂志, 2007, 35(4): 295-304.
[4] National Committee for Clinical Laboratory Standards. method comparison and bias estimation using patient samples EP09-A2 [J]. Clin Laborat Stand Instit, 2002, 22(19):1-52.
[5] 府伟灵, 徐克前. 临床生物化学检验[M]. 5版. 北京: 人民卫生出版社, 2011: 218-220.
[6] Wenger N K. 2011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician [J]. Clin Cardiol, 2012, 35(1): 3-8.
[7] 贺 延, 田东华, 吕俊刚, 等. 脑钠素与非ST段抬高型心肌梗死冠状动脉病变程度的关系[J]. 武警医学, 2009, 20(9): 808-809.
[8] 杨 丽, 彭 辉, 刘 琴, 等. 探讨血清心肌标志物与急性冠脉综合征患者危险分层的相关性[J]. 标记免疫分析与临床, 2014, 21(2): 127-131.
[9] 康可人, 吴培钿, 李悦琳, 等. 抗心型脂肪酸结合蛋白单克隆抗体制备、鉴定和在侧向免疫层析方法中的应用[J]. 中国生物工程杂志, 2013, 38(1):72-78.
PDF(593 KB)

Accesses

Citation

Detail

Sections
Recommended

/